Increasing prevalence of antimicrobial resistance in intensive care units

Critical Care Medicine

Volumn 29, Issue 4 SUPPL., 2001, Pages

  Fridkin, S K ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

Antibiotics; Bacterial infections; Candida; Cross infection; Drug resistance; Government; Infection control; Intensive care; Nosocomial; Surveillance

Indexed keywords

ANTIINFECTIVE AGENT; CEPHALOSPORIN; CIPROFLOXACIN; IMIPENEM; NAFCILLIN; OFLOXACIN; OXACILLIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; DRUG USE; HAND WASHING; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; PATIENT CARE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; REVIEW;

EID: 0035054062     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200104001-00002     Document Type: Review

References (38)

1. Antimicrobial resistance in hospitals and outpatients in the United States: The increasing importance of the intensive care unit
2. Magnitude and prevention of nosocomial infections in the intensive care unit
3. Hospital Infection Control Practices Advisory Committee: Guideline for isolation precautions in hospitals. Part I. Evolution of isolation practices
4. The role of understaffing in central venous catheter-associated bloodstream infections
5. The role of understaffing and overcrowding in recurrent outbreaks of staphylococcal infection in a neonatal special-care unit
6. Comparative efficacy of alternative handwashing agents in reducing nosocomial infections in intensive care units
7. Increasing handwashing in an intensive care unit
8. Nosocomial infection rates in adult and pediatric intensive care units in the United States
9. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance
10. Emergence of vancomycin-resistant Enterococcus in New York City
11. Antimicrobial-drug resistance
12. Bloodstream infections with vancomycin-resistant enterococci
13. Antibiotic-resistant Gram-negative bacteria in the critical care setting
14. Epidemiologic perspectives of Enterobacter for the infection control professional
15. Emerging antimicrobial resistance and the immunocompromised host
16. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center
17. Focused microbiologic surveillance by specific hospital unit as a sensitive means of defining antimicrobial resistance problems
18. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland
19. Antimicrobial resistance in hospital organisms and its relation to antibiotic use
20. Resistance surveillance programs and the incidence of Gram-negative bacillary resistance to amikacin from 1967-1985
21. Trends in antibiotic utilization and bacterial resistance: Report of the National Nosocomial Resistance Surveillance Group
22. National Nosocomial Infections Surveillance (NNIS) report, data summary from January 1990-May 1999, Issued June 1999
23. Nosocomial infections in coronary care units in the United States
24. Nosocomial infections in medical intensive care in the United States
25. Antimicrobial resistance in intensive care units
26. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993
27. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center
28. Treatment failure due to extended spectrum. B-lactamase
29. Detection of extended-spectrum B-lactamases n clinical isolates of Klebsiella pneumoniae and Escherichia coli
30. Trends in antimicrobial drug prescribing among office-based physicians in the United States
31. Antifungal susceptibility testing
32. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis
33. Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients
34. Epidemiology of nosocomial fungal infections
35. The epidemiology of hematogenous candidiasis caused by different Candida species
36. National surveillance of nosocomial blood stream infection due to Candida albicans: Frequency of occurrence and antifungal susceptibility in the SCOPE Program
37. Surveillance of antimicrobial use and antimicrobial resistance in U.S. Hospitals: Project ICARE Phase 2
38. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals